A Canadian Federal Court decision (July 9, 2018) is a victory not only for Dr. Peter Doshi who filed a suit to gain access to pharmaceutical data, against the Attorney General of Canada; it is a victory for “open access” and affirmation of the importance of  “freedom of expression.” “Freedom of expression certainly includes the…

Read More

FDA documents obtained under the Freedom of Information Act, revealed that the FDA has been concealing from the medical community and the public serious research misconduct; including fraud, deception, avoidable risks for human subjects — even deaths — that occurred in clinical trials. The FDA documents were obtained by Charles Seife, a journalism professor at New…

Read More

1967-1968: Grünenthal executives were put on trial in Aachen, Germany The indictment charged the company with intent to commit bodily harm and involuntary manslaughter.  The central defendant was Dr. Heinrich Mückter, an indicted Nazi war criminal, who was the company’s chief scientist and head of research. Mückter was credited with the development of thalidomide and…

Read More

NIH AIDS Research Chief Rewrote Safety Report – AP Wed, 15 Dec 2004 John Solomon of The Associated Press continues his documented expose of the inner workings of the AIDS Division of theNational Institutes of Health (NIH). At the same time that the Los Angeles Times and Congfressional hearings focused on major conflicts of interest…

Read More

UK reports the FDA Conceals Vital Data on Prescription Drugs – Independent Sun, 12 Jun 2005 The entire world has trusted the FDA to ensure that only safe and effective drugs are approved for marketing–other agencies, lacking the necessary resources often followed FDA’s lead. However, such deferrence is no longer viable. An investigation by the…

Read More

Cholesterol Myths Debunked–Bad News for Statin Drug manufacturers Fri, 11 Jul 2003 The demise of hormone replacement therapy (HRT) is not the only case of medical fraud perpetrated by the medical establishment whose practitioners’ professional judgment and clinical practice is too often guided by the pharmaceutical industry. A major scientific review of the cholesterol lowering…

Read More

Antidepressant Makers Withhold Data on Children – Washington Post Thu, 29 Jan 2004 A front page article in The Washington Post addresses the key issue undermining public health and safety. Drug companies conceal unfavorable clinical trial findings: the tests failed to demonstrate that antidepressants are either safe or beneficial for children. The truth is finally…

Read More